| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5888386 | Experimental and Molecular Pathology | 2011 | 10 Pages |
Abstract
⺠Tumor-initiating cells derived from an atypical meningioma have been identified. ⺠These meningioma-initiating cells have the ability to self-renew and differentiate. ⺠Microarray studies identified aberrant cell-cycle genes CDKN2A, p14ARF, and CDKN2B. ⺠CD44 and ALCAM/CD166 may be biomarkers for meningioma-initiating cells. ⺠Meningioma-initiating cells are useful for modeling meningioma development.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Prakash Rath, Douglas C. Miller, N. Scott Litofsky, Douglas C. Anthony, Qi Feng, Craig Franklin, Lirong Pei, Alan Free, Jimei Liu, Mingqiang Ren, Mark D. Kirk, Huidong Shi,